| Sandeep S. Chaudhary, M.d. Apc | |
|
9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 | |
| (619) 443-0282 | |
| Not Available |
| Full Name | Sandeep S. Chaudhary, M.d. Apc |
|---|---|
| Speciality | Internal Medicine |
| Location | 9850 Genesee Ave Ste 320, La Jolla, California |
| Authorized Official Name and Position | Teri L Fleck (OFFICE MANAGER) |
| Authorized Official Contact | 6194430282 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sandeep S. Chaudhary, M.d. Apc 9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 Ph: (619) 443-0282 | Sandeep S. Chaudhary, M.d. Apc 9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 Ph: (619) 443-0282 |
| NPI Number | 1124043872 |
|---|---|
| Provider Enumeration Date | 07/13/2006 |
| Last Update Date | 09/11/2007 |
| Medicare PECOS PAC ID | 2668480476 |
|---|---|
| Medicare Enrollment ID | O20060404000824 |
News Archive
A temple in Thailand that offers medical care and shelter for HIV-positive people is becoming "overcrowded by the living," as antiretroviral drugs provided by the government are enabling people to live longer with the disease, the International Herald Tribune reports.
According to a new study, published in the Journal of Clinical Endocrinology and Metabolism, health scientists at the Universities of Bath and Birmingham found that by changing the timing of when you eat and exercise, people can better control their blood sugar levels.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124043872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A66677 (California) | Primary |
| Provider Name | Sandeep S Chaudhary |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1417055872 PECOS PAC ID: 1557345741 Enrollment ID: I20040615001536 |
News Archive
A temple in Thailand that offers medical care and shelter for HIV-positive people is becoming "overcrowded by the living," as antiretroviral drugs provided by the government are enabling people to live longer with the disease, the International Herald Tribune reports.
According to a new study, published in the Journal of Clinical Endocrinology and Metabolism, health scientists at the Universities of Bath and Birmingham found that by changing the timing of when you eat and exercise, people can better control their blood sugar levels.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
› Verified 7 days ago
News Archive
A temple in Thailand that offers medical care and shelter for HIV-positive people is becoming "overcrowded by the living," as antiretroviral drugs provided by the government are enabling people to live longer with the disease, the International Herald Tribune reports.
According to a new study, published in the Journal of Clinical Endocrinology and Metabolism, health scientists at the Universities of Bath and Birmingham found that by changing the timing of when you eat and exercise, people can better control their blood sugar levels.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
› Verified 7 days ago
Prima Primary Medical Association, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 Fax: 858-202-0055 | |
Scripps Clinic Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, 201 N, La Jolla, CA 92037 Phone: 858-554-6158 | |
La Jolla Personal Physicians Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9834 Genesee Ave Ste 400, La Jolla, CA 92037 Phone: 858-587-4773 Fax: 858-587-4785 | |
Essential Healthcare Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Avenue, Suite 820, La Jolla, CA 92037 Phone: 858-453-5200 Fax: 858-453-5160 | |
Rhona H. Fink, Md & Julie A. Papatheofanis, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Ave, Suite 370, La Jolla, CA 92037 Phone: 858-362-0616 | |
Robert I Fox, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Ave, #910, La Jolla, CA 92037 Phone: 858-457-2023 Fax: 858-457-2721 | |
Uc San Diego Student Health Service Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9500 Gilman Drive, La Jolla, CA 92093 Phone: 858-534-2135 Fax: 858-534-0814 |